Venezuela - español - Instituto Nacional de Higiene

laboratorios spefar venezolanos, s.a. - rivaroxaban - comprimidos recubiertos - 20 mg

Venezuela - español - Instituto Nacional de Higiene

bayer, s.a. venezuela - rivaroxaban - comprimidos recubiertos - 20 mg

Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - agentes antitrombóticos - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

eurofarma peru s.a.c. - droguerÍa - comprimido recubierto - por comprimido - - rivaroxaban

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

eurofarma argentina s.a. argentina - rivaroxaban 20 mg - comprimido recubierto - cada comprimido recubierto contiene: rivaroxaban 20 mg

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

xinetix pharma s.a.s. [co] colombia - rivaroxaban 20 mg - comprimidos recubiertos - cada comprimido recubierto contiene: rivaroxaban 20 mg

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios cinfa s.a. - piroxicam - comprimido dispersable - 20 mg - piroxicam 20 mg - piroxicam

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

bayer s.a. - rivaroxaban; - comprimido recubierto - por comprimido; rivaroxaban 20.000000 mg; - rivaroxaban

Venezuela - español - Instituto Nacional de Higiene

laboratorios spefar venezolanos s.a. - rivaroxaban - comprimidos recubiertos - 10 mg

Venezuela - español - Instituto Nacional de Higiene

laboratorios spefar venezolanos, s.a. - rivaroxaban - comprimidos recubiertos - 15 mg